Post‐COVID‐19 pulmonary fibrosis: Mechanisms, biomarkers, and therapeutic perspectives
Urvinder Kaur Sardarni,
No information about this author
Siddappa N. Byrareddy
No information about this author
Clinical and Translational Discovery,
Journal Year:
2025,
Volume and Issue:
5(1)
Published: Feb. 1, 2025
Abstract
Post‐COVID‐19
pulmonary
fibrosis
(post‐CPF)
has
emerged
as
a
serious
complication
with
profound
implications
for
long‐term
respiratory
health.
This
short
review
explores
the
multifactorial
mechanisms
underlying
post‐CPF,
emphasising
role
of
oxidative
stress,
epithelial‐to‐mesenchymal
transition
(EMT),
and
dysregulated
immune
responses.
Key
signalling
pathways,
such
TGF‐β,
WNT,
Cadherin,
are
pivotal
in
progression,
offering
potential
therapeutic
targets.
Biomarkers,
MUC4,
KRT5,
ATP12A
show
promise
early
detection
targeting,
they
share
molecular
features
idiopathic
(IPF)
fibrotic
interstitial
lung
diseases
(f‐ILDs),
suggesting
opportunities
to
repurpose
antifibrotic
therapies.
Despite
these
advancements,
significant
gaps
remain
understanding
cellular
hindering
effective
management
post‐CPF.
Addressing
challenges
through
targeted
approach
is
critical
improving
outcomes
survivors
severe
COVID‐19.
Language: Английский
Identification and validation of CDC20 and ITCH as ubiquitination related biomarker in idiopathic pulmonary fibrosis
Shulei Sun,
No information about this author
Yubao Wang,
No information about this author
Jing Feng
No information about this author
et al.
Hereditas,
Journal Year:
2025,
Volume and Issue:
162(1)
Published: April 1, 2025
Abstract
Purpose
Ubiquitination
plays
a
crucial
role
in
various
diseases.
This
study
aims
to
explore
the
potential
ubiquitination
related
genes
IPF.
Methods
The
gene
microarray
dataset
GSE24206
was
obtained
from
GEO
database.
Subsequently,
through
differential
expression
analysis
and
molecular
signatures
database,
we
1734
differentially
expressed
742
genes.
Through
venn
diagram
analysis,
53
Then,
gene-ontology
(GO)
enrichment
Kyoto
Encyclopedia
of
Genes
Genomes
(KEGG)
pathway
protein-protein
interactions
(PPI)
set
(GSEA)
were
applied
for
Finally,
CDC20
ITCH
IPF
patients
cells
validated
by
qPCR
western
blot
assay.
Results
A
total
(36
up-regulated
17
down-regulated
genes)
identified
between
6
healthy
controls.
GO
KEGG
mainly
involved
regulation
protein
ubiquitination,
post-translational
modification
ubiquitin
mediated
proteolysis.
PPI
results
demonstrated
that
these
interacted
with
each
other.
GSEA
some
hub
epithelial
mesenchymal
transition,
inflammatory
response,
hypoxia,
apoptosis.
experiment
level
consistent
bioinformatics
results.
Conclusion
We
analysis.
other
may
influence
development
transition
response.
Our
research
findings
provide
insights
into
mechanisms
fibrosis
evidence
therapeutic
targets
fibrosis.
Language: Английский